Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man
The development of effective vaccines continues to be a key goal for public health bodies, governments, funding bodies and pharmaceutical companies. With new vaccines such as Shingrix targeting Shingles and Bexsero for Meningitis B, licensed in recent years, today’s population can be prote...
Main Authors: | Amy Flaxman, Katie J. Ewer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/6/3/43 |
Similar Items
-
Methods for measuring T-cell memory to vaccination: from mouse to man
by: Flaxman, A, et al.
Published: (2018) -
Advances in Infectious Disease Vaccine Adjuvants
by: Jingyi Fan, et al.
Published: (2022-07-01) -
Nanoformulations with <i>Leishmania braziliensis</i> Antigens Triggered Controlled Parasite Burden in Vaccinated Golden Hamster (<i>Mesocricetus auratus</i>) against Visceral Leishmaniasis
by: Jennifer Ottino, et al.
Published: (2022-10-01) -
Zika virus—an update on the current efforts for vaccine development
by: Victória Alves Santos Lunardelli, et al.
Published: (2021-03-01) -
Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs
by: Malcolm S. Duthie, et al.
Published: (2022-10-01)